688
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Characterization of microRNAs and lncRNAs in early-stage squamous cell carcinoma based on the analysis of TCGA datasets

, , , , , , , & ORCID Icon show all
Pages 698-705 | Received 23 Dec 2019, Accepted 20 Jul 2020, Published online: 04 Aug 2020

References

  • Freddie B, Jacques F, Isabelle S, et al. Global cancer statistics 2018: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J Clinicians. 2018;68(6):394–424.
  • Song X, Kong F, Zong Z, et al. Mir-124 and mir-142 enhance cisplatin sensitivity of non-small cell lung cancer cells through repressing autophagy via directly targeting sirt1. RSC Adv. 2019;9(9):5234–5243.
  • Tang RX, Chen WJ, He RQ, et al. Identification of a RNA-seq based prognostic signature with five lncRNAs for lung squamous cell carcinoma. Oncotarget. 2017;8(31):50761–50773.
  • Sui J, Xu SY, Han J, et al. Integrated analysis of competing endogenous RNA network revealing lncRNAs as potential prognostic biomarkers in human lung squamous cell carcinoma. Oncotarget. 2017;8(39):65997–66018.
  • Bonelli MA, Cavazzoni A, Saccani F, et al. Inhibition of pi3k pathway reduces invasiveness and epithelial-to-mesenchymal transition in squamous lung cancer cell lines harboring pik3ca gene alterations. Mol Cancer Ther. 2015;14(8):1916–1927.
  • Anastasiadou E, Jacob LS, Slack FJ. Non-coding RNA networks in cancer. Nat Rev Cancer. 2018;18(1):5–18.
  • Sui J, Li YH, Zhang YQ, et al. Integrated analysis of long non-coding RNA-associated ceRNA network reveals potential lncRNA biomarkers in human lung adenocarcinoma. Int J Oncol. 2016;49(5):2023–2036.
  • Yi J, Li S, Wang C, et al. Potential applications of polyphenols on main ncRNAs regulations as novel therapeutic strategy for cancer. Biomed Pharmacother. 2019;113:108703. [cited 2020 Jun 03]
  • Wang P, Xu J, Wang Y, et al. An interferon-independent lncRNA promotes viral replication by modulating cellular metabolism. Science. 2017;358(6366):1051–1055.
  • Xu W, Yang T, Wang B, et al. Differential expression networks and inheritance patterns of long non-coding RNAs in castor bean seeds. Plant J. 2018;95(2):324–340.
  • Ning P, Wu Z, Hu A, et al. Integrated genomic analyses of lung squamous cell carcinoma for identification of a possible competitive endogenous RNA network by means of TCGA datasets. Peerj. 2018;6(16):e4254. [cited 2020 Jun 03]
  • Wang G, Chen H, Liu J. The long noncoding RNA LINC01207 promotes proliferation of lung adenocarcinoma. American Journal of Cancer Research. 2015;5(10):3162–3173.
  • Zhao Y, Lin H, Jiang J, et al. TBL1XR1 as a potential therapeutic target that promotes epithelial‐mesenchymal transition in lung squamous cell carcinoma. Exp Ther Med. 2018;17(1):91–98.
  • Wei Y, Zhang X. Transcriptome analysis of distinct long non-coding RNA transcriptional fingerprints in lung adenocarcinoma and squamous cell carcinoma. Tumor Biol. 2016;37(12):16275–16285.
  • Petty TL. Early diagnosis of lung cancer. Hosp Pract (1995). 2001;36(5):9–10.
  • Zhang Y, Sui J, Shen X, et al. Differential expression profiles of micrornas as potential biomarkers for the early diagnosis of lung cancer. Oncol Rep. 2017;37(6):3543–3553.
  • Zheng HT, Shi DB, Wang YW, et al. High expression of lncRNA MALAT1 suggests a biomarker of poor prognosis in colorectal cancer. Int J Clin Exp Path. 2014;7(6):3174–3181.
  • Perge P, Decmann Á, Pezzani R, et al. Analysis of circulating extracellular vesicle-associated micrornas in cortisol-producing adrenocortical tumors. Endocrine. 2018;59(2):280–288.
  • Kim YJ, Hwang KC, Kim SW, et al. Potential mirna-target interactions for the screening of gastric carcinoma development in gastric adenoma/dysplasia. Int J Med Sci. 2018;15(6):610–616.
  • Zhao P, Ma W, Hu Z, et al. Up-regulation of mir-340-5p promotes progression of thyroid cancer by inhibiting bmp4. J Endocrinol Invest. 2018;41(10):1165–1172.
  • Wapinski O, Chang HY. Long noncoding RNAs and human disease. Trends Cell Biol. 2011;21(6):354–361.
  • Thomson DW, Dinger ME. Endogenous microRNA sponges: evidence and controversy. Nat Rev Genet. 2016;17(5):272–283.
  • Karreth FA, Pandolfi PP. ceRNA cross-talk in cancer: when ce-bling rivalries go awry. Cancer Discov. 2013;3(10):1113–1121.
  • Karreth FA, Reschke M, Ruocco A, et al. The BRAF pseudogene functions as a competitive endogenous RNA and induces lymphoma in vivo. Cell. 2015;161(2):319–332.
  • Poliseno L, Pandolfi PP. PTEN ceRNA networks in human cancer. Methods. 2015;77–78:41–50.
  • Cian G, Aoife ML. Pseudogenes provide evolutionary evidence for the competitive endogenous RNA hypothesis. Mol Biol Evol. 2018;35(12):2886–2899.
  • Yin H, Wang X, Zhang X, et al. Integrated analysis of long noncoding RNA associated-competing endogenous RNA as prognostic biomarkers in clear cell renal carcinoma. Cancer Sci. 2018;109(10):3336–3349.
  • Kehao L, Hui G, Qiulei Z, et al. Gene and lncRNA co-expression network analysis reveals novel ceRNA network for triple-negative breast cancer. Sci Rep. 2019;9(1):15122. [cited Jun 03]
  • Hyun JP, Ping J, Soyeon K, et al. 3′ UTR shortening represses tumor-suppressor genes in trans by disrupting ceRNA crosstalk. Nat Genet. 2018;50(6):783–789.